Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12976
Celularity
CELU
$38.5M
| $59.2K | ﹤0.01% |
+99,054
| New | +$95.1K |
|
12977
CALL
PSQ Holdings
PSQH
$18.3M
| $59.2K | ﹤0.01% |
9,800
+6,273
| +178% | +$55.5K |
|
12978
CALL
OFS Capital
OFS
$52.4M
| $59.1K | ﹤0.01% |
+16,700
| New | +$61.1K |
|
|
MOB
12979
CALL
Mobilicom Ltd
MOB
$57.3M
| $59K | ﹤0.01% |
+11,500
| New | +$67.3K |
|
12980
PUT
TaskUs
TASK
$750M
| $59K | ﹤0.01% |
12,600
-14,400
| -53% | -$87.4K |
|
12981
Coherus Oncology
CHRS
$198M
| $59K | ﹤0.01% |
42,111
-191,835
| -82% | -$313K |
|
|
CTOR
12982
Citius Oncology
CTOR
$95.2M
| $58.9K | ﹤0.01% |
+90,586
| New | +$72.2K |
|
12983
PUT
Elicio Therapeutics
ELTX
$48.4M
| $58.6K | ﹤0.01% |
15,000
-1,800
| -11% | -$18.1K |
|
12984
CALL
CVRx
CVRX
$80.5M
| $58.6K | ﹤0.01% |
11,400
-7,300
| -39% | -$47.1K |
|
12985
PUT
Alight
ALIT
$318M
| $58.3K | ﹤0.01% |
5,205
-4,685
| -47% | -$66.3K |
|
|
BHST
12986
BioHarvest Sciences
BHST
$37.6M
| $58.2K | ﹤0.01% |
20,652
+5,899
| +40% | +$22.5K |
|
12987
CALL
Blend Labs
BLND
$322M
| $58K | ﹤0.01% |
33,900
-11,300
| -25% | -$18K |
|
12988
PUT
Comtech Telecommunications
CMTL
$43.7M
| $58K | ﹤0.01% |
27,600
+17,500
| +173% | +$67.3K |
|
|
MRM
12989
MEDIROM Healthcare Technologies
MRM
$6.6M
| $57.8K | ﹤0.01% |
+56,102
| New | +$63K |
|
|
DDL
12990
PUT
Dingdong
DDL
$485M
| $57.7K | ﹤0.01% |
29,900
-10,200
| -25% | -$25.3K |
|
|
SCNX
12991
Scienture Holdings
SCNX
$13.5M
| $57.7K | ﹤0.01% |
+164,854
| New | +$62.6K |
|
|
QNTM
12992
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$151
| $57.4K | ﹤0.01% |
15,863
| – | – |
|
|
NGEN
12993
CALL
NervGen Pharma
NGEN
$232M
| $57.3K | ﹤0.01% |
+27,800
| New | +$86.3K |
|
12994
CALL
Universal Electronics
UEIC
$66.5M
| $57.2K | ﹤0.01% |
12,000
-3,000
| -20% | -$12.5K |
|
|
ABTC
12995
PUT
American Bitcoin Corp
ABTC
$586M
| $57.1K | ﹤0.01% |
5,593
-567
| -9% | -$8.68K |
|
12996
CALL
Conduent
CNDT
$253M
| $57.1K | ﹤0.01% |
39,100
-19,400
| -33% | -$30.1K |
|
|
LPA
12997
Logistic Properties of the Americas
LPA
$99.9M
| $56.9K | ﹤0.01% |
+16,927
| New | +$56.4K |
|
|
TUYA
12998
PUT
Tuya Inc
TUYA
$1.08B
| $56.8K | ﹤0.01% |
32,300
+16,100
| +99% | +$35.1K |
|
12999
PUT
enGene Therapeutics
ENGN
$127M
| $56.7K | ﹤0.01% |
+32,800
| New | +$134K |
|
|
FENG
13000
Phoenix New Media
FENG
$17.3M
| $56.7K | ﹤0.01% |
36,617
+1,581
| +5% | +$2.67K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.